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http://dxObjective: Available data on outcomes of combined proximal stent grafting with distal bare stenting for man-
agement of aortic dissection are limited. This is a systematic review of outcomes of this approach.
Methods: Studies involving combined proximal stent grafting with distal bare stenting for management of aortic
dissection were systematically searched and reviewed.
Results: A total of 4 studies were included, with 108 patients treated for acute (n ¼ 54) and chronic (n ¼ 54)
aortic dissection. Technical success rate was 95.3% (range, 84-100). The 30-day mortality was 2.7% (range,
0%-5%). Morbidity rate within 30 days was 51.8% (range, 0%-65%) and included stroke (2.7%), paraplegia
(2.7%), retrograde dissection (1.8%), renal failure (14.8%), severe cardiopulmonary complications (5.5%),
and bowel ischemia (0.9%). Incidence of type I endoleak was 9.2% (10/108). During follow-up, 5 patient deaths
(4.6%) were related to aortic rupture or aortic repair. Reintervention rate was from 12.9%. Two cases of delayed
retrograde type A dissection (1.9%) and 1 case of aortobronchial fistula (0.9%) were reported. Most common
delayed complication was thoracic stent-graft migration (4.7%). Device failure rate was 9.2%. Favorable aortic
remodeling was observed: studies reporting midterm follow-up of the true lumen demonstrated high rates of
false-lumen regression and true-lumen expansion. At 12 months, complete false-lumen thrombosis was ob-
served at the thoracic level in 70.4% and at the abdominal level in 13.5%.
Conclusions: Combined proximal stent grafting with distal bare stenting for management of aortic dissection ap-
pears to be a reasonable approach for typeB aortic dissection, clearly improved true-lumenperfusion and diameter
although failing to suppress false-lumen patency completely. Contemporary information on this approach is
mainly provided by small series with a wide range of results. (J Thorac Cardiovasc Surg 2013;145:1431-8)Acute dissection is the most common fatal aortic catastro-
phe, and the surgical treatment of Stanford type B acute aor-
tic dissection remains a formidable challenge. The standard
strategy for uncomplicated Stanford type B acute aortic dis-
section is medical management, with surgical intervention
reserved for cases complicated by rupture, malperfusion, in-
tractable pain, uncontrolled hypertension, and aneurysmal
dilatation.
During the past decade, thoracic endovascular aortic re-
pair (TEVAR) has been increasingly used to treat this con-
dition when intervention has been necessary. The aim is to
cover the entry tear to direct aortic flow preferentially into
the true lumen. In one review, endovascular repair of acute
complicated type B aortic dissection was associated with
a lower 30-day mortality (2.8%) than that of open repair,
and TEVAR was therefore regarded as the surgical therapyhe Department of Outcomes Research, St. George’s Vascular Institute,
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The Journal of Thoracic and Carof choice.1 Even if it is associated with a lower mortality
than open surgery, however, stent grafting of complicated
chronic type B aortic dissection remains controversial, de-
spite thrombosing the false lumen adjacent to the stent-
graft, because of concerns regarding durability.
Tsai and colleagues2 showed that the natural course of
false-lumen partial thrombosis in type B aortic dissection
has a worse prognosis than that of a completely patent
false lumen.3 Complete exclusion of the false lumen,
however, could improve the prognosis of this disease.
To promote true-lumen expansion and false-lumen throm-
bosis, devices with bare metal stents that extend into the
thoracoabdominal aorta have been used in an attempt to
induce aortic remodeling. The ultimate aim of this tech-
nique is to prevent aortic aneurysmal evolution and
rupture and to decrease the number of additional proce-
dures required.
The aim of this study was to provide a systematic review
of series that describe the outcomes of combined proximal
stent grafting with distal bare stenting for the management
of thoracic aortic dissection.MATERIALS AND METHODS
Search Strategy
A literature search was undertaken to identify all published studies in
the past 10 years reporting the combination of proximal stent graftingdiovascular Surgery c Volume 145, Number 6 1431
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The Jwith distal bare stents for management of aortic dissection. Candidate
studies in English were sought through a computerized search of
MEDLINE (National Library of Medicine, Bethesda, Md) databases for
the period of 1950 to September 2012. Key words entered in this search
were ‘‘thoracic aorta’’ or ‘‘bare stent’’ ‘‘dissection,’’ ‘‘endovascular,’’
and ‘‘PETTICOAT.’’ Additionally, manual evaluation of the reference
lists of the retrieved articles and reviews on this area subject was
undertaken.
Study Selection
Studies were considered for inclusion on the basis of the following cri-
teria: (1) reporting on combined proximal stent grafting with distal bare
stenting for management of aortic dissection, including at least 5 patients
treated with this method, and reporting on clinical outcome. Studies con-
taining duplicate data were excluded, and the studies from the same authors
with the most recent or the best-documented material were used for
analysis.
Data Extraction
Data were extracted regarding demographics, comorbidity, case selec-
tion (proportion of acute and chronic dissections, proportion of patients
with symptoms, operative details, technical success, and early and midterm
outcomes (endoleak, retrograde dissection, aortic rupture, stroke, parapare-
sis or paraplegia, renal failure, bowel ischemia, severe cardiopulmonary
complications, 30-day and midterm mortalities, freedom from
reintervention).
Severe morbidity was defined as mortality related to aortic repair or any
of following nonfatal adverse events occurring within the postoperative
hospital period: central nervous system complication (stroke or spinal
cord ischemia with permanent deficit), type I endoleak, retrograde type I
dissection, acute renal failure (attested by the need to initiate hemodialysis
for the first time), cardiac failure, pulmonary distress syndrome or severe
lung infection, bowel ischemia, aortobronchial fistula, and unplanned re-
turn to surgery.
Perioperative severe morbidity was defined as severe morbidity oc-
curring within the first 30 postoperative days. Midterm morbidity was
defined as severe morbidity occurring after the first 30 postoperative
days.
RESULTS
Search Results
Four studies were integrated after a literature search and
the exclusion of duplicated publications3-6 (Table 1).ection
Study period Study type N
— Retrospective cohort 12 58
2003-2010 Retrospective cohort 31 57
2007-2009 Prospective cohort 40
2005-2011 Retrospective cohort 25
of patients except as marked. *Mean  SD.
ournal of Thoracic and Cardiovascular SurCase Selection
Patient demographic characteristics, presenting features,
and comorbidities are shown in Tables 1 and 2. The mean
age was 57.5 years, and 75.9% of the patients were male.
The indication for endovascular repair (Table 3) was the
presence of features of complicated aortic dissection
(15 type A vs 93 type B; 54 acute vs 54 chronic). The
most common comorbidities were hypertension (87.9%),
hyperlipidemia (18%), renal failure (15.6%), and cardiac
disease (12%).
The most commonly stated indication for intervention
was malperfusion arising from branch vessel obstruction
or true-lumen collapse (76/108, 70.3%). Other indications
included refractory hypertension (41/108, 37.9%), refrac-
tory chest pain (36/108, 33.3%), rapid aortic enlargement
(5 mm within 3 months) or transaortic diameter greater
than 40 mm (35/108, 32.4%), and periaortic effusion or he-
matoma (10/108, 9.2%). Acute and chronic dissections
could not be separated for the purpose of analysis.
Technical Success (Tables 4 and 5)
The Cook Zenith dissection device (Cook Medical Inc,
Bloomington, Ind) was the most common deployed graft
(96/108, 88.8%). A median of 1.27 stent-grafts (range,
1-3) and 1.27 bare stents (range, 1-3) were used per patient.
The technical success rate was 95.3% (range, 84%-100%),
with a median operative duration of 141 minutes (range,
40-397 minutes). Supra-aortic branch revascularization
was performed in 23.1% of the patients (25/108). Adjunct
endovascular procedures were required in 32 patients
(29.6%). One patient (0.9%) underwent conversion to
open surgery because a bare metal strut became lodged in
the distal aorta.
Perioperative Outcomes (Table 6)
Perioperative outcomes were those occurring within the
first 30 postoperative days. The overall 30-day mortality
was 2.7% (3/108). The early morbidity rate was 51.8%
(range, 0%-65%). Acute renal failure was the most com-
mon early complication (14.8%, 16/108), with 6 patients
in this group requiring dialysis. In studies that reported en-
doleaks according to subtype, the global incidence of endo-
leak was 12% (13/108); type I incidence was 5.5% (6/108)
and type II was 6.4% (7/108). The incidence of earlyAge* (y) Male
Indication
Type A Type B Acute Chronic
.7  10 83% 16.6% 83.4% 0% 100%
.8  12.5 71% 41.9% 58.1% 81% 19%
58  11 70% 0% 100% 60% 40%
56  12 88% 0% 100% 20% 80%
gery c June 2013
TABLE 2. Case selection: Patient comorbidities
HTA Diabetes Smoking Hyperlipidemia
Cardiac
disease
Chronic
obstructive
pulmonary
disease
Renal
failure
ASA class
I II III IV
Nienaber et al6 100% — — 16.6% 16.6% — 50% 0% 0% 91.6% 8.4%
Hofferberth et al4 74.1% 9.6% 29% 22.6% 16.1% — — — — — —
Lombardi et al3 92.5% 7.5% 58.3% 7.5% 10.4% 2.6% 5% — — — —
Melissano et al5 92% 12% 52% 32% 8% 0% 15% 0% 32% 52% 16%
All data are percentages of patients. ASA, American Society of Anesthesiologists; HTA, hypertension.
Canaud et al Expert Reviewretrograde dissection was 1.8% (2/108), and periprocedural
aortic rupture occurred in 1.8% (2/108). The incidence
of neurologic complications was 5.4% (6/108); of these
complications, equal numbers were stroke and paraplegia
or paraparesis. The early reintervention rate was 4.6%,
and reintervention was required for renal artery occlusion,
bowel ischemia, type II endoleak, and bare-stent
misdeployment.Midterm Outcomes (Table 7)
Midterm outcomes were defined as those occurring after
30 days. The all-cause mortality was 3.8% (4/105). There
were 2 cases of delayed retrograde type A dissection
(1.9%) and 1 case of aortobronchial fistula (0.9%). The
most common delayed complication was stent-graft migra-
tion (5/105, 4.7%). The incidence of type I endoleak was
3.8% (4/105). No type II endoleaks were reported. Delayed
aortic rupture was reported in 1.9% (2/105). Reintervention
was necessary in 8.5% of patients (4%-13.3%) for compli-
cations such as retrograde type A dissection, type I endo-
leak, stent-graft migration, and aortobronchial fistula
(Table 8).Severe Morbidity Rate
Severe morbidity was defined as mortality related to aor-
tic repair or any of the following nonfatal adverse events oc-
curring within the postoperative hospital period: central
nervous system complication (stroke or spinal cord ische-
mia with permanent deficit), type I endoleak, retrograde
type I dissection, acute renal failure (attested by the need
to initiate hemodialysis for the first time), cardiac failure,
pulmonary distress syndrome or severe lung infection,TABLE 3. Case selection: Indication for aortic repair
Branch vessel obstruction
or compromise, or correction
of true-lumen collapse
Periaortic effusion
or hematoma
Nienaber et al6 100% 0%
Hofferberth et al4 100% 0%
Lombardi et al3 67.5% 20%
Melissano et al5 24% 8%
All data are percentages of patients.
The Journal of Thoracic and Carbowel ischemia, aortobronchial fistula, and unplanned re-
turn to surgery. The overall severe morbidity rate was
33.3% (36/108). The perioperative severe morbidity rate
was 17.6% (19/108). The midterm severe morbidity rate
was 16.1% (17/105).Device Performance
The rate of device failure was 9.2% (10/108). Compo-
nent separation or device migration necessitating secondary
interventions was reported in 5 patients. One case of focally
ruptured Zenith dissection stent was reported, and 4 cases of
a stent body misalignment of Cook Zenith dissection stent
were reported.Aortic Remodeling (Table 9)
Rates of complete false-lumen thrombosis ranged from
31.2% to 75% at the thoracic level and from 3.1% to
25.9% at the abdominal level. These data were not always
complete, and the total number of patients for whom results
were available was low. Studies reporting midterm follow-
up of the true lumen demonstrated high rates of false-lumen
regression and of true-lumen expansion (Table 9). Nienaber
and colleagues6 reported an increase in the true-lumen size
and a concomitant decrease in the false-lumen size along
the dissected aorta at 12 months, with a completely throm-
bosed thoracic false lumen observed in 75% of the patients.
The fate of the false lumen at the abdominal aorta level was
not reported.
Hofferberth and coworkers4 reported increased true-
lumen perfusion and diameter after a mean follow-up of
57.3 months, although perfusion of the abdominal orResistant
hypertension
Persistent pain
or symptoms
Transaortic growth 5 mm
within 3 mo (or transaortic
diameter 40 mm)
0% 0% 0%
0% 0% 0%
65% 77.5% 52.5%
68% 20% 56%
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TABLE 4. Technical aspect
Graft types
SGs per
patient
Bare stents
per patient Adjunct procedures
Procedure time
(min, mean ± SD)
Time from dissection
to intervention
(d, median and range)
Nienaber et al6 SG: Talent (66.6%), Excluder
(16.6%), Valiant (8.3%),
Zenith (8.3%); bare stent:
Sinus (41.6%), Fortress
(50%), Z stent (8.4%)
1.08 (1-2) 1.08 (1-2) 0% (0/12) 70  15 —
Hofferberth et al4 Zenith Cook dissection 2.9 (1-5) 61.2% (19/31); SG (6/31):
Iliac, renal, superior
mesenteric arteries;
ascending aorta open repair
(13/31)
— 10.4 (1-1095)
Lombardi et al3 Zenith Cook dissection 1.27 (1-3) 1.37 (0-3) 37.5% (15/40); bare stent
(9/40): Iliac, renal, superior
mesenteric arteries;
carotid–subclavian bypass
(3/40); carotid–carotid
bypass (3/40)
163 (40-397) 20 (0-78)
Melissano et al5 Zenith Cook dissection 1.32 (1-3) 1.28 (1-2) 96% (24/25); bare stent: Iliac,
renal, superior mesenteric
arteries (4/25); humeral
thrombectomy (1/25);
carotid-subclavian bypass
(2/25); carotid–carotid
bypass (17/25)
— —
SG, Stent-graft; SD, standard deviation.
Expert Review Canaud et althoracic aortic false lumen was still observed in 74% of the
patients.
Melissano and colleagues5 noted a significant increase
(98%) in true-lumen volumes at both the thoracic (115%)
and abdominal segments (63%) at a mean follow-up of
57.3 months. At midterm follow-up (1 and 2 years), the
overall aortic volume tended to decrease to preoperative
values. The rate of false-lumen thrombosis was not re-
ported. The abdominal segment, after initial true-lumen ex-
pansion, failed to remodel with stable true-lumen volume
and had a tendency toward enlargement of the overall ab-
dominal aortic volume as a result of abdominal false-
lumen expansion.TABLE 5. Technical success and mortality
Mean
follow-up
(mo)
Technical
success rate 1-y survival
Overall
aortic-related
mortality
Nienaber et al6 — 100% 91.6% 8.3% (1/12) 0
Hofferberth et al4 57.3 97% 93.7% 6.4% (2/31) 3.2
Lombardi et al3 — 100% 90% 7.9% (3/38) 5
Melissano et al5 38  17 84% 100% 0% (0/25) 0
Data represent percentages of patients except as noted.
1434 The Journal of Thoracic and Cardiovascular SurLombardi and colleagues3 reported an increase in true-
lumen size and a concomitant decrease in the false-lumen
size in the dissected aorta at 12 months. A completely
thrombosed thoracic false lumen was observed in 31% of
their patients. Perfusion of the false lumen in thoracic and
abdominal aortic segments was still present in 68.8% and
96.8% of their patients, respectively.
DISCUSSION
One of the drawbacks of stent grafting for complicated
thoracic aortic dissection is that the thrombosis of the false
lumen is frequently not complete, despite thrombosing the
false lumen adjacent to the stent-graft during the procedure,30-d aortic related mortality >30-d aortic-related mortality
Rate Etiology Rate Etiology
% (0/12) 8.3% (1/12) Aortic rupture
in mo 11
% (1/31) Stent-graft misdeployment:
surgical conversion
3.3% (1/30)
% (2/40) Aortic rupture on d 11;
sudden death on day 29
5% (2/38) Aortic rupture
on d 81
% (0/25) 0% (0/25)
gery c June 2013
TABLE 6. Morbidity within 30 days
Mean
follow-up
(mo)
Overall
morbidity
30-d morbidity
Aortic
rupture
Type I
endoleak
Type II
endoleak Stroke
Paraparesis
or paraplegia
Retrograde
dissection Cardiopulmonary
Renal
failure
Bowel
ischemia
Nienaber
et al6
— 0% (0/12) 0% 0% — 0% 0% 0% 0% 0% 0%
Hofferberth
et al4
57.3 22.5% (7/31) 0% (0/31) 3.3% (1/31) 3.3% (1/31) 0% 0% 0% 3.3% (1/31) 12.9% (4/31) 0%
Lombardi
et al3
— 65% (26/40) 5% (2/40) 2.5% (1/40) 7.5% (3/40) 7.5% (3/40) 5% (2/40) 5% (2/40) 12% (5/40) 17.5% (7/40) 2.5% (1/40)
Melissano
et al5
38  17 52% (13/25) 0% (0/25) 16% (4/25) 12% (3/25) 0% 4% (1/25) 0% 0% 20% (5/25) 0%
Data represent percentages of patients except as noted.
Canaud et al Expert Reviewas a consequence of retrograde flow through the residual
reentry tear or intimal fenestrations related to branch
vessels.
This incomplete thrombosis exposes patients to in-
creased risk of late aneurysmal degeneration and therefore
aortic rupture. It has been reported by Tsai and col-
leagues2 that the natural course of false-lumen partial
thrombosis in type B aortic dissection has a worse progno-
sis than that of a completely patent false lumen. Complete
exclusion of the false lumen should therefore clearly be
the aim wherever possible.2 To promote true-lumen expan-
sion and false-lumen thrombosis, some authors have
proposed the use of bare metal stents in the distal thora-
coabdominal aorta. The PETTICOAT, (or Provisional Ex-
Tension To Induce COmplete ATtachment) technique, was
first reported in 2005 by Mossop and colleagues,7 and in
2006 a series of 12 cases was reported.6 This technique
eliminates the entry tear and increases the true-lumen di-
ameter in the distal aorta through a combination of stent
grafting and bare metal stenting of the visceral and infrare-
nal segments.
To compare the results of proximal stent grafting with
distal bare stenting against stent-graft placement without
distal bare stenting for management of aortic dissection,
a review of series reporting results for the latter technique
in the management of complicated acute and chronicTABLE 7. Morbidity after 30 days
Mean
follow-up
(mo)
Overall
morbidity
Aortic
rupture
Type I
endoleak
Type II
endoleak
St
m
Nienaber
et al6
— 16.6% (2/12) 8.3% (1/12) 8.3% (1/12) —
Hofferberth
et al4
57.3 16.6% (5/30) 3.3% (1/30) 3.3% (1/30) — 3.3
Lombardi
et al3
— 18.4% (7/38) 2.6% (1/38) 2.6% (1/38) 0% 5.2
Melissano
et al5
38  17 12% (3/25) 0% 4% (1/25) 0% 8
Data represent percentages of patients except as noted.
The Journal of Thoracic and Caraortic dissection was performed (Tables 10-12).8-27 The
technical success rates reported for proximal stent
grafting with distal bare stenting for management of
aortic dissection were high (95.3%) and were similar to
reported success rates of established endovascular
techniques that used stent-grafts without distal bare stent-
ing. The mean 30-day mortality after combined proximal
stent grafting with distal bare stenting for acute and
chronic aortic dissection in this study was 2.7%. This
mortality is similar to rates recently reported by several
authors describing results of TEVAR for acute and
chronic dissection. Of especial note, however, was the
rate of severe morbidity. The pooled rate of severe mor-
bidity in this series was 33.3% (36/108). A meta-
analysis describing the results of TEVAR for acute and
chronic dissection reported a major complication rate of
11.1%  1.4%.16 The most critical complications were
related to retrograde extension of the dissection into the
ascending aorta, neurologic complications, and aortic rup-
ture. This more extensive approach was associated with
slightly higher rates of dissection into the ascending aorta
(3.7 vs 1.8%), neurologic complications (5.5 vs 3.1%),
and aortic rupture (3.7 vs 2.5%); however, patients treated
in this study represent a difficult patient subgroup, with
63.8% of the patients being seen with malperfusion or
impending rupture. Eggebrecht and associates8 reported>30-d morbidity
ent-graft
igration
Retrograde
dissection Cardiopulmonary
Renal
failure
Aortobronchial
fistula
0% 0% 0% 0% 0%
% (1/30) 3.3% (1/30) 0% 0% 3.3% (1/30)
% (2/38) 2.6% (1/38) 2.6% (1/38) 2.6% (1/38) 0%
% (2/25) 0% 0% 0% 0%
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TABLE 8. Secondary interventions
Mean
follow-up (mo)
<30 d >30 d
Rate Cause Rate Cause
Nienaber et al6 — 0% (0/12) 8.3% (1/12) Type I endoleak
Hofferberth et al4 57.3 3.2% (1/31) Bare stent misdeployment 13.3% (4/30) Retrograde type A dissection,
proximal stent-graft migration,
aortobronchial fistula, type I
endoleak
Lombardi et al3 — 7.5% (3/40) Liver and gall bladder ischemia,
renal artery stenting, renal artery
stenting
7.9% (3/38) Retrograde type A dissection,
retrograde type A dissection and
stent-graft migration, type I
endoleak
Melissano et al5 38  17 4% (1/25) Type II endoleak 4% (1/25) Stent-graft migration
Expert Review Canaud et althe most favorable outcomes. Among 12 patients with
a malperfusion syndrome, the overall severe morbidity
was 16.6%: 1 patient died of an aortic rupture, and an-
other received an additional stent-graft for a type I endo-
leak. This favorable result may be explained by the fact
that this group advocated a staged approach to the proce-
dure, allowing recovery from the acute insult of dissection
and the initial procedure before evaluation of the need for
extension of the graft with the bare metal components.
Persistence of a distal malperfusion syndrome after prox-
imal covered endograft placement is uncommon. Nie-
naber and colleagues6 only reported this issue in 12
patients among a cohort of 100 patients (12%). This sug-
gests that distal bare stenting could be planned only after
evaluation after primary entry tear closure, rather than
performed as a single-stage extensive repair of the thora-
coabdominal aorta.
Achievement of a complete false-lumen thrombosis is
challenging, and pursuing this goal compounds the risks
of multiple procedures, cumulative radiation dose, and con-
trast exposure. By treating the entire thoracoabdominal
aorta, combined proximal stent grafting with distal bare
stenting, should limit the number of adjunct procedures re-
quired. The reintervention rate was 16.6% for severeTABLE 9. Aortic remodeling
Change in TL-FL ratio
Tho
Com
Nienaber et al6 At 1 y: before stenting TL:FL¼ 4/25¼ 0.16,
after stenting TL:FL ¼ 23/11 ¼ 2.1
75%
Hofferberth et al4 At 1 y: before stenting TL expansion/
FL ¼ 84/332 ¼ 0.25, after stenting
TL:FL ¼ 216/248 ¼ 0.87
66.6%
Melissano et al5 At 2 y: FL reduction ¼ 65%; before stenting
TL:FL ¼ 84/332 ¼ 0.25, after stenting
TL:FL ¼ 216/248 ¼ 0.87
Lombardi et al3 At 1 y: TL increased (P<.05), FL decreased
(P<.05)
31.2%
Data represent percentages of patients except as noted. FL, False lumen; TL, true lumen.
1436 The Journal of Thoracic and Cardiovascular Surcomplications, such as renal arterial occlusion, type I endo-
leak, retrograde dissection, aortic rupture, and aortobron-
chial fistula.
Hofferberth and coworkers4 reported that adjunct bare
metal stenting did not compromise branch vessel perfu-
sion. This statement needs to be qualified. Adjunct intrao-
perative endovascular procedures to maintain patency of
visceral or iliac arteries were required for 19 arteries.
When compared with results of a recent study of TEVAR
without distal bare stenting for management of compli-
cated aortic dissection,16 the rate of adjunct endovascular
procedures was significantly lower (1% vs 17.6%) than
after bare metal stent deployment in the distal thoracoab-
dominal aorta.
Device concerns have also been reported. Bertoglio and
coworkers28 reported the risk of stent misalignment, prob-
ably resulting from excessive manipulation of the delivery
system or during catheter manipulation during adjunct or
secondary procedures. Melissano and colleagues5 reported
1 focally ruptured bare stent. Lombardi and colleagues3
reported component separation or device migration neces-
sitating secondary interventions in 2 patients. Hofferberth
and coworkers4 reported 1 case in which the bare stent be-
came dislodged in the distal aorta, necessitatingracic aorta FL thrombosis Abdominal aorta FL thrombosis
plete Partial Complete Partial
(9/12) 8.3% (1/12) — —
(18/27) 33.4% (9/27) 25.9% (7/27) 70.3% (19/27)
— — — —
(10/32) 68.8% (22/32) 3.1% (1/32) 81.3% (26/32)
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TABLE 10. Endovascular stent-graft repair without distal bare stenting for management of acute and chronic complicated type B aortic dissection
First author Year n Acute (n)
Technical
success
Retrograde
dissection Stroke Paraplegia Renal failure
Adjunct
distal
reperfusion
Aortic
rupture
30-d
mortality
Eggebrecht8
(meta-analysis)
2006 609 248 98% 1.9% 1.9% 0.8% NA NA 2.3% 5.3%
Dialetto9 2005 56 14 100% 4% 0% 0% NA 0% 1.7% 10.7%
Nathanson10 2005 40 23 95% NA 2.5% 2.5% 13% 0% 0% 2.5%
Sayer11 2008 78 38 100% 1.2% 0% 2.5% NA 0% 3.8% 5.1%
B€ockler12 2009 54 24 93% 3.7% 0% 0% NA 0% 0% 11.1%
Kische13 2009 180 37 98.3% 1.8% 3.9% 2.8% NA 2.7% 4.2% 5%
Younes14 2010 23 11 100% 0% 5.5% 5.5% 0% 0% 0% 5.5%
Parsa15 2010 55 22 100% 0% 0% 2% 1.8% 0% 0% 2%
Yang16 2012 61 33 100% 1.6% 1.6% 1.6% 1.6% 1.6% 6.5% 6.5%
Overall 1156 450 (38.9%) 98.3% 1.8% 1.9% 1.2% NA 1% 2.5% 5.5%
Data represent percentages of patients except as noted. NA, Not available.
Canaud et al Expert Reviewconversion to open surgery and leading to the death of the
patient.
The combination of proximal stent grafting with distal
bare stenting for management of aortic dissection clearly
improved true-lumen perfusion and diameter; however, it
apparently failed to suppress false-lumen patency com-
pletely. At 1-year, false-lumen patency was still present
in 29.6% of the patients at the thoracic level and in
86.5% of the patients at the abdominal level. Data on
patients for whom complete imaging was available be-
yond this period were limited. Yang and colleagues16
studied aortic remodeling after TEVAR for acute and
chronic dissection, and they reported a comparable rate
of false-lumen patency of 19.4% at the thoracic level
at 1 year.
This review has several limitations. Although it is the
only review to date on combined proximal stent grafting
with distal bare stenting for management of aortic dissec-
tion, the pooled results are weakened by the lack of stan-
dardization in reporting patients’ specific data and end
points. In addition, the data are insufficient for separate
analyses of outcomes for acute or chronic dissections. Fur-
thermore, we specifically focused the review on clinical
outcome. Finally, some studies with small sample sizesTABLE 11. Endovascular stent-graft repair without distal bare stenting fo
Year N
Technical
success
Retrograde
dissection Stroke
Conrad17 2009 33 100 9 3
Khoynezhad18 2009 28 90 3.5 3.3
Shu19 2010 45 100 0 0
White20 2011 85 100 0 9.4
Qin21 2012 124 100 24 0.8
Ehrlich22 2013 29 100 3.4 6.8
Overall 28 450 450 450 450
Data represent percentages of patients except as noted. NA, Not available.
The Journal of Thoracic and Carwere included, whereas a larger number of patients is
needed for better identification of statistically significant
differences.
CONCLUSIONS
In this analysis, the combination of proximal stent graft-
ing with distal bare stenting for the management of aortic
dissection clearly improved true-lumen perfusion and di-
ameter; however, it failed to suppress false-lumen patency
completely and carried nontrivial risks of severe morbid-
ity. Distal bare stenting could be proposed as a second
stage to treat cases of persistent distal malperfusion syn-
drome after careful evaluation of the immediate results
of primary entry tear closure, rather than as part of an ex-
tensive single-stage repair of the thoracoabdominal aorta.
Nevertheless, no reliable long-term data exist to assess
the durability of combined proximal stent grafting with
distal bare stenting for the management of aortic dissec-
tion, and contemporary conclusions spring mainly from
relatively small case series or retrospective studies. Fur-
thermore, results of management of acute and chronic dis-
section should be reported separately to allow a more
accurate analysis. Prospective trials of combined proximal
stent grafting with distal bare stenting versus stent graftingr management of acute complicated type B aortic dissection
Paraplegia
Renal
failure
Adjunct distal
reperfusion
Aortic
rupture
30-d
mortality
12 0 0 6 12
0 10 3.5 0 11
0 4.4 0 0 4.4
9.4 9.4 4.7 14 10.6
0.8 NA 13.7 0 0
0 0 20 6.8 17
450 450 450 450 450
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TABLE 12. Endovascular stent-graft repair without distal bare stenting for management of chronic complicated type B aortic dissection
Year N
Technical
success
Retrograde
dissection Stroke Paraplegia
Renal
failure
Adjunct
distal reperfusion
Aortic
rupture
30-d
mortality
Kim23 2009 72 97.2% 0% 0% 0% 1.4% 0% 0% 0%
Xu24 2010 84 91.7% 0% 0% 0% 4.8% 0% 4.8% 1.2%
Czerny25 2010 14 85.7% 0% 0% 0% 0% 0% 0% 0%
Kang26 2011 76 96% 3.9% 1.3% 0% 0% 0% 0% 5%
Andacheh27 2012 73 99% 5.4% 1% 1% 0% 0% 2.7% 14%
Total 319 95.8% 2.1% 1.8% 0.3% 1.5% 0% 1.8% 4.7%
Data represent percentages of patients except as noted.
Expert Review Canaud et alwithout distal bare stenting are needed to assess outcomes
of this extensive approach.References
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